Kyle Mikson
Stock Analyst at Canaccord Genuity
(2.04)
# 2,965
Out of 5,173 analysts
127
Total ratings
35.05%
Success rate
-4.34%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Maintains: Hold | $30 → $22 | $19.26 | +14.23% | 3 | Mar 13, 2026 | |
| XGN Exagen | Maintains: Buy | $15 → $10 | $2.85 | +250.88% | 6 | Mar 11, 2026 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $0.90 | +11.36% | 7 | Mar 5, 2026 | |
| GH Guardant Health | Maintains: Buy | $125 → $135 | $84.96 | +58.90% | 11 | Feb 20, 2026 | |
| GRAL GRAIL | Maintains: Buy | $105 → $80 | $49.13 | +62.83% | 6 | Feb 20, 2026 | |
| BDSX Biodesix | Maintains: Buy | $20 | $14.69 | +36.15% | 6 | Feb 17, 2026 | |
| ILMN Illumina | Maintains: Hold | $130 → $150 | $123.79 | +21.17% | 15 | Jan 26, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $72.14 | +135.65% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $19.14 | +4.49% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $49.14 | +62.80% | 3 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $8 | $3.94 | +103.05% | 8 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $285 | $200.09 | +42.44% | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $50 | $25.75 | +94.17% | 6 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $104.91 | +0.09% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $33.54 | +28.21% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $116.35 | +41.81% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.39 | +115.83% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.25 | +140.00% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.21 | +873.71% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $9.83 | +14,915.26% | 1 | Mar 30, 2021 |
Caris Life Sciences
Mar 13, 2026
Maintains: Hold
Price Target: $30 → $22
Current: $19.26
Upside: +14.23%
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $15 → $10
Current: $2.85
Upside: +250.88%
Quantum-Si incorporated
Mar 5, 2026
Maintains: Hold
Price Target: $1.5 → $1
Current: $0.90
Upside: +11.36%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $125 → $135
Current: $84.96
Upside: +58.90%
GRAIL
Feb 20, 2026
Maintains: Buy
Price Target: $105 → $80
Current: $49.13
Upside: +62.83%
Biodesix
Feb 17, 2026
Maintains: Buy
Price Target: $20
Current: $14.69
Upside: +36.15%
Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130 → $150
Current: $123.79
Upside: +21.17%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $72.14
Upside: +135.65%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $19.14
Upside: +4.49%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $49.14
Upside: +62.80%
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $3.94
Upside: +103.05%
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $200.09
Upside: +42.44%
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $25.75
Upside: +94.17%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $104.91
Upside: +0.09%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $33.54
Upside: +28.21%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $116.35
Upside: +41.81%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.39
Upside: +115.83%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.21
Upside: +873.71%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $9.83
Upside: +14,915.26%